RYZ 801
Alternative Names: 225Ac-GPC3; 225Ac-GPC3 - PeptiDream/RayzeBio; RYZ-801Latest Information Update: 28 Feb 2024
At a glance
- Originator PeptiDream; RayzeBio
- Developer RayzeBio
- Class Antineoplastics; Drug conjugates; Macrocyclic compounds; Peptides; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver cancer; Renal cancer